Nocicepteurs et médiateurs dans la douleur aiguë inflammatoire

Price, 2000, The mammalian sodium channel BNC1 is required for normal touch sensation, Nature, 407, 1007, 10.1038/35039512 Garcia-Anoveros, 1997, The molecules of mechanosensation, Annu Rev Neurosci, 20, 567, 10.1146/annurev.neuro.20.1.567 Cervero, 1996, What is a noxious stimulus?, Pain Forum, 5, 157, 10.1016/S1082-3174(96)80020-1 Handwerker, 1993, Psychophysiology of experimentally induced pain, Physiol Rev, 73, 639, 10.1152/physrev.1993.73.3.639 Kumazawa, 1998, Primitivism and plasticity of pain-implication of polymodal receptors, Neurosci Res, 32, 9, 10.1016/S0168-0102(98)00060-1 Walters, 1994, Injury-related behavior and neuronal plasticity, an evolutionary perspective on sensitization, hyperalgesia, and analgesia, Int Rev Neurobiol, 36, 325, 10.1016/S0074-7742(08)60307-4 Hunt, 1985, Peptide- and non-peptide-containing unmyelinated primary afferents, the parallel processing of nociceptive information, Philos Trans R Soc Lond B Biol Sci, 308, 283, 10.1098/rstb.1985.0028 Vulchanova, 1996, Differential distribution of two ATP-gated channels (P2X receptors) determined by immunocytochemistry, Proc Natl Acad Sci USA, 93, 8063, 10.1073/pnas.93.15.8063 Molliver, 1997, IB4-binding DRG neurons switch from NGF to GDNF dependence in early postnatal life, Neuron 19, 849, 10.1016/S0896-6273(00)80966-6 Amann, 1995, The non-peptide NK1 receptor antagonist SR140333 produces long-lasting inhibition of neurogenic inflammation, but does not influence acute chemo- or thermonociception in rats, Naunyn Schmied Arch Pharmacol, 352, 201, 10.1007/BF00176775 Cao, 1998, Primary afferent tachykinins are required to experience moderate to intense pain, Nature, 392, 390, 10.1038/32897 Baloh, 2000, The GDNF family ligands and receptors –implications for neural development, Curr Opin Neurobiol, 10, 103, 10.1016/S0959-4388(99)00048-3 Stucky, 1999, Isolectin (4) -positive and -negative nociceptors are functionally distinct, J Neurosci, 19, 6497, 10.1523/JNEUROSCI.19-15-06497.1999 Basbaum, 1999, Distinct neurochemical features of acute and persistent pain, Proc Natl Acad Sci USA, 96, 7739, 10.1073/pnas.96.14.7739 Martin, 1999, Inflammation-induced up-regulation of protein kinase Cγ immunoreactivity in rat spinal cord correlates with enhanced nociceptive processing, Neuroscience, 88, 1267, 10.1016/S0306-4522(98)00314-5 Cesare, 1999, Ion channels gated by heat, Proc Natl Acad Sci USA, 96, 7658, 10.1073/pnas.96.14.7658 Kress, 1999, Capsaicin, protons and heat, new excitement about nociceptors, Trends Pharmacol Sci, 20, 112, 10.1016/S0165-6147(99)01294-8 Sterner, 1999, Novel natural vanilloid receptor agonists, new therapeutic targets for drug development, Trends Pharmacol Sci, 20, 459, 10.1016/S0165-6147(99)01393-0 Szallasi, 1999, Vanilloid (Capsaicin) receptors and mechanisms, Pharmacol Rev, 51, 159 Szolcsányi, 1993, Actions of capsaicin on sensory receptors, 1 Nagy, 1999, Similarities and differences between the responses of rat sensory neurons to noxious heat and capsaicin, J Neurosci, 19, 10647, 10.1523/JNEUROSCI.19-24-10647.1999 Caterina, 1997, The capsaicin receptor, a heat-activated ion channel in the pain pathway, Nature, 389, 816, 10.1038/39807 Tominaga, 1998, The cloned capsaicin receptor integrates multiple pain-producing stimuli, Neuron, 21, 531, 10.1016/S0896-6273(00)80564-4 Jordt, 2000, Potentiation of the capsaicin receptor determined by a key extracellular site, Proc Natl Acad Sci USA, 97, 8134, 10.1073/pnas.100129497 Vyklicky, 1999, Temperature coefficient of membrane currents induced by noxious heat in sensory neurones in the rat, J Physiol, 517, 181, 10.1111/j.1469-7793.1999.0181z.x Caterina, 1999, A capsaicin-receptor homologue with a high threshold for noxious heat, Nature, 398, 436, 10.1038/18906 Nagy, 1999, Noxious heat activates all capsaicin-sensitive and also a sub-population of capsaicin-insensitive dorsal root ganglion neurons, Neuroscience, 88, 995, 10.1016/S0306-4522(98)00535-1 Hwang, 2000, Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances, Proc Natl Acad Sci USA, 97, 6155, 10.1073/pnas.97.11.6155 Smart, 2000, The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1), Br J Pharmacol, 129, 227, 10.1038/sj.bjp.0703050 Szallasi, 2000, New perspectives on enigmatic vanilloid receptors, Trends Neurosci, 23, 491, 10.1016/S0166-2236(00)01630-1 Premkumar, 2000, Induction of vanilloid receptor channel activity by protein kinase C, Nature, 408, 985, 10.1038/35050121 Zygmunt, 1999, Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, 400, 452, 10.1038/22761 Reeh, 2001, Molecular physiology of proton transduction in nociceptors, Curr Opin Pharmacol, 1, 45, 10.1016/S1471-4892(01)00014-5 Waldmann, 1997, A proton-gated cation channel involved in acid-sensing, Nature, 386, 173, 10.1038/386173a0 Reeh, 1996, Tissue acidosis in nociception and pain, Prog Brain Res, 113, 143, 10.1016/S0079-6123(08)61085-7 Chen, 1998, A sensory neuron-specific, proton-gated ion channel, Proc Natl Acad Sci USA, 95, 10240, 10.1073/pnas.95.17.10240 Bland-Ward, 2000, P2X receptors mediate ATP-induced primary nociceptive neurone activation, J Auton Nerv Syst, 81, 146, 10.1016/S0165-1838(00)00122-3 Ding, 2000, ATP, P2X receptors and pain pathways, J Auton Nerv Sys, 81, 289, 10.1016/S0165-1838(00)00131-4 Hamilton, 2000, ATP as a peripheral mediator of pain, J Auton Nerv Syst 2001, 81, 187, 10.1016/S0165-1838(00)00137-5 Burnstock, 2001, Purine-mediated signalling in pain and visceral perception, Trends Pharmacol Sci, 22, 182, 10.1016/S0165-6147(00)01643-6 Gold, 1999, Tetrodotoxin-resistant Na+ currents and inflammatory hyperalgesia, Proc Natl Acad Sci USA, 96, 7645, 10.1073/pnas.96.14.7645 Waxman, 1999, The molecular pathophysiology of pain: abnormal expression of sodium channel genes and its contributions to hyperexcitability of primary sensory neurons, Pain, Suppl 6, S133, 10.1016/S0304-3959(99)00147-5 Baker, 2001, Involvement of Na+ channels in pain pathways, Trends Pharmacol Sci, 22, 27, 10.1016/S0165-6147(00)01585-6 Wood, 2001, Voltage-gated sodium channels, Curr Opin Pharmacol, 1, 17, 10.1016/S1471-4892(01)00007-8 Waxman, 2000, The neuron as a dynamic electrogenic machine: modulation of sodium-channel expression as a basis for functional plasticity in neurons, Philos Trans R Soc Lond B Biol Sci, 355, 199, 10.1098/rstb.2000.0559 Akopian, 1996, A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons, Nature, 379, 257, 10.1038/379257a0 Sangameswaran, 1997, A novel tetrodotoxin-sensitive, voltage-gated sodium channel expressed in rat and human dorsal root ganglia, J Biol Chem, 272, 14805, 10.1074/jbc.272.23.14805 Dib-Hajj, 1998, NaN, a novel voltage-gated Na channel, is expressed preferentially in peripheral sensory neurons and down-regulated after axotomy, Proc Natl Acad Sci USA, 95, 8963, 10.1073/pnas.95.15.8963 Tate, 1998, Two sodium channels contribute to the TTX-R sodium current in primary sensory neurons, Nat Neurosci, 1, 653, 10.1038/3652 Akopian, 1999, The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways, Nat Neurosci, 6, 541, 10.1038/9195 Renganathan, 2000, Alpha-SNS produces the slow TTX-resistant sodium current in large cutaneous afferent DRG neurons, J Neurophysiol, 84, 710, 10.1152/jn.2000.84.2.710 Gold, 1998, Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro, J Neurosci, 18, 10345, 10.1523/JNEUROSCI.18-24-10345.1998 Ragsdale, 1996, Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels, Proc Natl Acad Sci U S A, 93, 9270, 10.1073/pnas.93.17.9270 Butterworth, 1990, Molecular mechanisms of local anesthesia: a review, Anesthesiology, 72, 711, 10.1097/00000542-199004000-00022 Dahl, 2000, Non-opioid postoperative analgesia, Acta Anaesthesiol Scand, 44, 1191, 10.1034/j.1399-6576.2000.441003.x LaMotte, 1991, Neurogenic hyperalgesia: psychophysical studies of underlying mechanisms, J Neurophysiol, 66, 190, 10.1152/jn.1991.66.1.190 Pedersen, 1996, Effect of preemptive nerve block on inflammation and hyperalgesia after human thermal injury, Anesthesiology, 84, 1020, 10.1097/00000542-199605000-00002 Gentili, 1999, The effect of a sciatic nerve block on the development of inflammation in carrageenan injected rats, Anesth Analg, 89, 979, 10.1213/00000539-199910000-00029 Tanaka, 1998, SNS Na+ channel expression increases in dorsal root ganglion neurons in the carrageenan inflammatory pain model, Neuroreport, 9, 967, 10.1097/00001756-199804200-00003 Schmidt, 1994, Silent and active nociceptors, structures, functions and clinical implications, vol. 2, 213 Dray, 1997, Kinins and their receptors in hyperalgesia, Can J Physiol Pharmacol, 75, 704, 10.1139/Y97-068 Calixto, 2000, Kinins in pain and inflammation, Pain, 87, 1, 10.1016/S0304-3959(00)00335-3 Cesare, 1999, Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat, Neuron, 23, 617, 10.1016/S0896-6273(00)80813-2 Aley, 2000, Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C, J Neurosci, 20, 4680, 10.1523/JNEUROSCI.20-12-04680.2000 Schanstra, 1998, The B1-agonist 〚des-Arg10〛 -kallidin activates transcription factor NF-kappaB and induces homologous upregulation of the bradykinin B1-receptor in cultured human lung fibroblasts, J Clin Invest, 101, 2080, 10.1172/JCI1359 Ahluwalia, 1999, B1 receptors as a new inflammatory target. Could this B the 1 ?, Trends Pharmacol Sci, 20, 100, 10.1016/S0165-6147(99)01321-8 Marceau, 1998, The B1 receptors for kinins, Pharmacol Rev, 50, 357 Poole, 1999, Hyperalgesia from subcutaneous cytokines, 59 Cartmell, 2000, Circulating interleukin-6 mediates the febrile response to localised inflammation in rats, J Physiol, 526, 653, 10.1111/j.1469-7793.2000.00653.x Versteeg, 1999, Cyclooxygenase-dependent signalling: molecular events and consequences, FEBS Lett, 445, 1, 10.1016/S0014-5793(99)00105-2 Smith, 2000, Cyclooxygenases: structural, cellular, and molecular biology, Ann Rev Biochem, 69, 145, 10.1146/annurev.biochem.69.1.145 Marnett, 1999, Cyclooxygenase 2 inhibitors: discovery, selectivity and the future, Trends Pharmacol Sci, 20, 465, 10.1016/S0165-6147(99)01385-1 Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J M, 343, 1520, 10.1056/NEJM200011233432103 Silverstein, 2000, Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis The CLASS STUDY: a randomized, controlled trial, JAMA, 284, 1247, 10.1001/jama.284.10.1247 Fitzgerald, 2001, The coxibs, selective inhibitors of cyclooxygenase-2, N Engl J M, 345, 433, 10.1056/NEJM200108093450607 Bley, 1998, The role of IP prostanoid receptors in inflammatory pain, Trends Pharmacol Sci, 19, 141, 10.1016/S0165-6147(98)01185-7 Nicol, 1997, Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons, J Neurophysiol, 77, 167, 10.1152/jn.1997.77.1.167 Lopshire, 1998, The cAMP transduction cascade mediates the prostaglandin E2 enhancement of the capsaicin-elicited current in rat sensory neurons: whole-cell and single-channel studies, J Neurosci, 18, 6081, 10.1523/JNEUROSCI.18-16-06081.1998 Evans, 1999, The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones, J Physiol, 516, 163, 10.1111/j.1469-7793.1999.163aa.x Zhang, 2001, Phorbol ester-induced inhibition of potassium currents in rat sensory neurons requires voltage-dependent entry of calcium, J Neurophysiol, 85, 362, 10.1152/jn.2001.85.1.362 Aley, 1998, Nitric oxide signaling in pain and nociceptor sensitization in the rat, J Neurosci, 18, 7008, 10.1523/JNEUROSCI.18-17-07008.1998 Chen, 1999, NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat, J Neurophysiol, 81, 963, 10.1152/jn.1999.81.3.963 Reuter, 1996, Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2, J Clin Invest, 98, 2076, 10.1172/JCI119013 Gilroy, 2000, New insights into the role of COX 2 in inflammation, J Mol M, 78, 121, 10.1007/s001090000094 Gilroy, 1999, Inducible cyclooxygenase may have anti-inflammatory properties, Nat M, 5, 698, 10.1038/9550 Willoughby, 2000, Resolution of inflammation, Int J Immunopharmacol, 22, 1131, 10.1016/S0192-0561(00)00064-3 Ricote, 1998, The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation, Nature, 391, 79, 10.1038/34178 Pahl, 1999, Activators and target genes of Rel/NF-κB transcription factors, Oncogene, 18, 6853, 10.1038/sj.onc.1203239 Makarov, 2000, B as a therapeutic target in chronic inflammation: recent advances, Mol Medicine Today, 6, 441, 10.1016/S1357-4310(00)01814-1 Mattson, 2001, B in neuronal plasticity and neurodegenerative disorders, J Clin Investig, 107, 247, 10.1172/JCI11916 Yin, 1998, The anti-inflammatory agents aspirin and salicylate inhibit the activity of IkappaB kinase-beta, Nature, 396, 77, 10.1038/23948 Rossi, 2000, Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase, Nature, 403, 103, 10.1038/47520 Huang, 1999, Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipooxygenase, Nature, 400, 378, 10.1038/22572 Han, 1998, AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis, Autoimmunity, 28, 197, 10.3109/08916939808995367 Saragovi, 2000, Development of pharmacological agents for targeting neurotrophins and their receptors, Trends Pharmacol Sci, 21, 93, 10.1016/S0165-6147(99)01444-3 Shu, 1999, Effects of trkB and trkC neurotrophin receptor agonists on thermal nociception: a behavioural and electrophysiological study, Pain, 80, 463, 10.1016/S0304-3959(99)00042-1 Mendell, 1999, Neurotrophins, nociceptors, and pain, Microsc Res Tech, 45, 252, 10.1002/(SICI)1097-0029(19990515/01)45:4/5<252::AID-JEMT9>3.0.CO;2-N Shu, 1999, Neurotrophins and hyperalgesia, Proc Natl Acad Sci USA, 96, 7693, 10.1073/pnas.96.14.7693 Koltzenburg, 1999, Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin, Eur J Neurosci, 11, 1698, 10.1046/j.1460-9568.1999.00590.x Thompson, 1999, Brain-derived neurotrophic factor is an endogenous modulator of nociceptive responses in the spinal cord, Proc Natl Acad Sci USA, 96, 7714, 10.1073/pnas.96.14.7714 Apfel, 1996, Nerve growth factor regulates the expression of brain-derived neurotrophic factor mRNA in the peripheral nervous system, Mol Cell Neurosci, 7, 134, 10.1006/mcne.1996.0010 Michael, 1997, Nerve growth factor treatment increases brain-derived neurotrophic factor selectively in TrkA-expressing dorsal root ganglion cells and in their central terminations within the spinal cord, J Neurosci, 17, 8476, 10.1523/JNEUROSCI.17-21-08476.1997 Brunig, 2001, BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABAA receptor surface expression, Eur J Neurosci, 13, 1320, 10.1046/j.0953-816x.2001.01506.x Kerr, 1999, Brain-derived neurotrophic factor modulates nociceptive sensory inputs and NMDA-evoked responses in the rat spinal cord, J Neurosci, 19, 5138, 10.1523/JNEUROSCI.19-12-05138.1999 Mannion, 1999, Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity, Proc Natl Acad Sci USA, 96, 9385, 10.1073/pnas.96.16.9385 van Rossum, 1997, Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors, Neurosci Biobehav Rev, 21, 649, 10.1016/S0149-7634(96)00023-1 Snijdelaar, 2000, Substance P, Eur J Pain, 121, 10.1053/eujp.2000.0171 Cocks, 2000, Protease-activated receptors: sentries for inflammation?, Trends Pharmacol Sci, 21, 103, 10.1016/S0165-6147(99)01440-6 Vergnolle, 2001, Protease-activated receptors in inflammation, neuronal signaling and pain, Trends Pharmacol Sci, 22, 146, 10.1016/S0165-6147(00)01634-5 Carlton, 2001, Peripheral excitatory amino acids, Curr Opin Pharmacol, 1, 52, 10.1016/S1471-4892(01)00002-9 Khasar, 1999, Epinephrine produces a beta-adrenergic receptor-mediated mechanical hyperalgesia and in vitro sensitization of rat nociceptors, J Neurophysiol, 81, 1104, 10.1152/jn.1999.81.3.1104 Malmberg, 2000, Protein kinase subtypes involved in injury-induced nociception, Prog Brain Res, 129, 51, 10.1016/S0079-6123(00)29005-5 Pertwee, 2001, Cannabinoid receptors and pain, Prog Neurobiol, 63, 569, 10.1016/S0301-0082(00)00031-9 Mazzari, 1996, N (2-hydroxyethyl) hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation, Eur J Pharmacol, 300, 227, 10.1016/0014-2999(96)00015-5 Richardson, 1998, Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors, Pain, 75, 111, 10.1016/S0304-3959(97)00213-3 Antunes Bras, 2001, Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats, Neuroscience, 103, 1073, 10.1016/S0306-4522(01)00034-3 Braz, 2001, Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overeproduction in sensory neurons, J Neurosci, 21, 781, 10.1523/JNEUROSCI.21-20-07881.2001 Stein, 1995, The control of pain in peripheral tissue by opioids, N Engl J M, 332, 1685, 10.1056/NEJM199506223322506 Kalso, 1997, Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review, Pain, 71, 127, 10.1016/S0304-3959(97)03344-7 Stein, 1999, Intraarticular morphine versus dexamethasone in chronic arthritis, Pain, 83, 525, 10.1016/S0304-3959(99)00156-6 Woolf, 1999, Transcriptional and posttranslational plasticity and the generation of inflammatory pain, Proc Natl Acad Sci USA, 96, 7723, 10.1073/pnas.96.14.7723 Aley, 1999, Role of protein kinase A in the maintenance of inflammatory pain, J Neurosci, 19, 2181, 10.1523/JNEUROSCI.19-06-02181.1999 Cox, 2000, Calcium channel blockers and pain therapy, Curr Rev Pain, 4, 488, 10.1007/s11916-000-0073-8 Vanegas, 2000, Effects of antagonists to high-threshold calcium channels upon spinal mechanisms of pain, hyperalgesia and allodynia, Pain, 85, 9, 10.1016/S0304-3959(99)00241-9 Catterall, 2000, Structure and regulation of voltage-gated Ca2+ channels, Annu Rev Cell Dev Biol, 16, 521, 10.1146/annurev.cellbio.16.1.521 Field, 2000, Further evidence for the role of the α2δ subunit of voltage dependent calcium channels in models of neuropathic pain, Br J Pharmacol, 131, 282, 10.1038/sj.bjp.0703604 Furst, 1999, Transmitters involved in antinociception in the spinal cord, Brain Res Bull, 48, 129, 10.1016/S0361-9230(98)00159-2 Yaksh, 1999, The spinal biology in humans and animals of pain states generated by persistent small afferent input, Proc Natl Acad Sci USA, 96, 7680, 10.1073/pnas.96.14.7680 Dickenson, 1997, The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord, Gen Pharmacol, 28, 633, 10.1016/S0306-3623(96)00359-X Baranauskas, 1998, Sensitization of pain pathways in the spinal cord: cellular mechanisms, Prog Neurobiol, 54, 349, 10.1016/S0301-0082(97)00067-1 Dingledine, 1999, The glutamate receptor ion channels, Pharmacol Rev, 51, 7 Johnson, 1987, Glycine potentiates the NMDA response in cultured mouse brain neurons, Nature, 325, 529, 10.1038/325529a0 Yu, 1999, Src, a molecular switch governing gain control of synaptic transmission mediated by N-methyl-D-aspartate receptors, Proc Natl Acad Sci USA, 96, 7697, 10.1073/pnas.96.14.7697 Andersen, 1996, The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study, Pain, 66, 51, 10.1016/0304-3959(96)02995-8 Warncke, 1997, Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo, Pain, 72, 99, 10.1016/S0304-3959(97)00006-7 Stubhaug, 1997, Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery, Acta Anaesthesiol Scand, 41, 1124, 10.1111/j.1399-6576.1997.tb04854.x Conn, 1997, Pharmacology and functions of metabotropic glutamate receptors, Annu Rev Pharmacol Toxicol, 37, 205, 10.1146/annurev.pharmtox.37.1.205 Fletcher, 1996, New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors, Pharmacol Ther, 70, 65, 10.1016/0163-7258(96)00014-9 Muth-Selbach, 1999, Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation, Anesthesiology, 91, 231, 10.1097/00000542-199907000-00032 Bjorkman, 1994, Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P, Pain, 57, 259, 10.1016/0304-3959(94)90001-9 Hill, 2000, NK1 (substance P) receptor antagonists - why are they not analgesic in humans?, Trends Pharmacol Sc, 21, 244, 10.1016/S0165-6147(00)01502-9 Kramer, 1998, Distinct mechanism for antidepressant activity by blockade of central substance P receptors, Science, 281, 1640, 10.1126/science.281.5383.1640 Woolf, 1998, Null mutations lacking substance: elucidating pain mechanisms by genetic pharmacology, Neuron, 20, 1063, 10.1016/S0896-6273(00)80487-0 Kehlet, 1999, Balanced analgesia: what is it and what are its advantages in postoperative pain?, Drugs, 58, 793, 10.2165/00003495-199958050-00002